catechin has been researched along with Infections, Pseudomonas in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Jian, S; Li, L; Li, W; Li, Y; Shi, F; Song, X; Tang, H; Wang, Y; Ye, G; Yin, Z; Zhao, L; Zhao, X; Zou, Y | 1 |
Betts, JW; Higgins, PG; Hornsey, M; La Ragione, RM; Lucassen, K; Salguero, FJ; Seifert, H; Wille, J | 1 |
Christiansen, G; Dueholm, MS; Geifman-Shochat, S; Kjelleberg, S; Meyer, RL; Nielsen, PH; Otzen, DE; Seviour, T; Stenvang, M; Søndergaard, MT; Vad, BS; Zeng, G | 1 |
Muller, M | 1 |
4 other study(ies) available for catechin and Infections, Pseudomonas
Article | Year |
---|---|
Epigallocatechin-3-gallate ameliorates liver injury secondary to Pseudomonas aeruginosa pneumonia.
Topics: Alanine Transaminase; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Catechin; Cytokines; Interleukin-6; Liver; Liver Diseases; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Catechin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Larva; Microbial Sensitivity Tests; Moths; Polyphenols; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment.
Topics: Amyloid; Bacterial Proteins; Benzothiazoles; Biofilms; Catechin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Thiazoles; Tobramycin | 2016 |
Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1.
Topics: Antioxidants; Bacterial Toxins; Burns, Inhalation; Catechin; Cell Line; Cell Proliferation; Cell Survival; Cystic Fibrosis; Diet Therapy; Humans; NAD(P)H Dehydrogenase (Quinone); Opportunistic Infections; Oxidation-Reduction; Oxidative Stress; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Quercetin; Respiratory Mucosa; Respiratory Tract Infections | 2009 |